NEU 2.99% $20.10 neuren pharmaceuticals limited

Acadia’s results could not have been better. Record revenue, two...

  1. 43 Posts.
    lightbulb Created with Sketch. 35
    Acadia’s results could not have been better. Record revenue, two franchises that are cash cows, and they even increased their year over year cash position! Any other permutation of Acadia is disingenuous. Plus they will be profitable in 2024 for the first time - if they don’t go on an acquisition spree. We talk on this message board about NEU being a prime candidate for acquisition. Well, so is Acadia, in my opinion, with revenues nearing $1 billion and massive tax loss that a big fish would desire.

    I am also of the view that NEU hit the ball out of the park with Trifinotide revenues coming in at a whopping $87 million US!! Holy moly!!! For the second full quarter of sales!! Wow.

    Anyone that doesn’t say WOW has an agenda.





 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.10
Change
-0.620(2.99%)
Mkt cap ! $2.569B
Open High Low Value Volume
$20.41 $20.45 $19.92 $5.947M 296.0K

Buyers (Bids)

No. Vol. Price($)
1 999 $20.10
 

Sellers (Offers)

Price($) Vol. No.
$20.19 10 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.